Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$849,033
+$152,196 QoQ
Shares Held
3,374
+5.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#2,702
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABLES CAPITAL MANAGEMENT INC. holds $11,549,324 across 11 Drug Manufacturers - General names. ABBV ranks #5 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,805 | $3,364,401 | |
| 2 | JNJ |
Johnson & Johnson
|
12,302 | $3,124,338 | |
| 3 | MRK |
Merck & Co., Inc.
|
16,302 | $2,094,807 | |
| 4 | PFE |
Pfizer Inc
|
36,400 | $876,512 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
3,374 | $849,033 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,190 | $414,287 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,990 | $377,756 | |
| 8 | AMGN |
Amgen Inc
|
962 | $348,359 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $849,033 | 3,374 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $696,837 | 3,204 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $754,930 | 3,304 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $765,008 | 3,304 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $650,412 | 3,504 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $982,229 | 4,688 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $833,057 | 4,688 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $723,369 | 3,663 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $804,085 | 4,688 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $817,264 | 4,488 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $695,505 | 4,488 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $668,981 | 4,488 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $595,237 | 4,418 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $672,222 | 4,218 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $674,236 | 4,172 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $559,924 | 4,172 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $638,983 | 4,172 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $676,322 | 4,172 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $564,888 | 4,172 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $450,033 | 4,172 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $469,934 | 4,172 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $933,613 | 8,627 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $924,383 | 8,627 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $755,638 | 8,627 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $846,998 | 8,627 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $636,415 | 8,353 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||